Word

RNA ACTUATOR

Status

Pending

Status Code

688

Status Date

Tuesday, May 14, 2024

Serial Number

97768020

Mark Type

4

Filing Date

Wednesday, January 25, 2023

Published for Opposition

Tuesday, March 19, 2024

Trademark Owner History

CAMP4 Therapeutics Corporation - Owner At Publication

Classifications

5 Pharmaceutical, therapeutic pharmaceuticals, and biopharmaceutical preparations and agents for the treatment of a variety of human and animal diseases and disorders, namely, autoimmune diseases and disorders, cardiovascular diseases and disorders, connective tissues diseases and disorders, dermatological diseases and disorders, enzyme deficiency diseases and disorders, gastrointestinal diseases and disorders, genetic diseases and disorders, genitourinary diseases and disorders, hematological diseases and disorders, immunoregulatory diseases and disorders, infectious diseases and disorders, inflammatory diseases and disorders, hepatic diseases and disorders, metabolic diseases and disorders, muscular diseases and disorders, neurological diseases and disorders, neuromuscular diseases and disorders, oncological diseases and disorders, ophthalmological diseases and disorders, rare diseases and disorders, renal diseases and disorders, reproductive disease and disorders, and respiratory diseases and disorders; nucleic acid-based therapeutic pharmaceuticals and therapeutic agents for the treatment of a variety of human and animal diseases and disorders, namely, autoimmune diseases and disorders, cardiovascular diseases and disorders, connective tissues diseases and disorders, dermatological diseases and disorders, enzyme deficiency diseases and disorders, gastrointestinal diseases and disorders, genetic diseases and disorders, genitourinary diseases and disorders, hematological diseases and disorders, immunoregulatory diseases and disorders, infectious diseases and disorders, inflammatory diseases and disorders, hepatic diseases and disorders, metabolic diseases and disorders, muscular diseases and disorders, neurological diseases and disorders, neuromuscular diseases and disorders, oncological diseases and disorders, ophthalmological diseases and disorders, rare diseases and disorders, renal diseases and disorders, reproductive disease and disorders, and respiratory diseases and disorders; chemicals for use in therapeutic product development and manufacturing processes in the medical field

1 Biological and chemical agents, namely, chemical preparations for scientific and research use; synthetic nucleic acids other than for medical or veterinary purposes; chemically modified nucleic acids, other than for medical or veterinary purposes; chemicals for use in biotherapeutics in the biochemical and chemical industries and excluding medical and veterinary purpose; biological preparations for use in industry and science; chemical agents, namely, chemical preparations for analyses in laboratories, other than for medical or veterinary purposes

42 Research and development of pharmaceutical, therapeutic and biopharmaceutical preparations and agents for the treatment of a variety of human and animal diseases and disorders, namely, autoimmune diseases and disorders, cardiovascular diseases and disorders, connective tissues diseases and disorders, dermatological diseases and disorders, enzyme deficiency diseases and disorders, gastrointestinal diseases and disorders, genetic diseases and disorders, genitourinary diseases and disorders, hematological diseases and disorders, immunoregulatory diseases and disorders, infectious diseases and disorders, inflammatory diseases and disorders, hepatic diseases and disorders, metabolic diseases and disorders, muscular diseases and disorders, neurological diseases and disorders, neuromuscular diseases and disorders, oncological diseases and disorders, ophthalmological diseases and disorders, rare diseases and disorders, renal diseases and disorders, reproductive disease and disorders, and respiratory diseases and disorders; research and development of technology in the field of pharmaceutical, therapeutic and biopharmaceutical preparations and agents; pharmaceutical drug development and drug discovery services; pharmaceutical research and analysis services using machine learning analytics relating to pharmaceutical drug development; scientific research, pharmaceutical research, medical research, technical consultation, and product development for others in the field of biotechnology and development of pharmaceutical, therapeutic, and biopharmaceutical preparations and agents

"RNA"

Trademark Events

Nov 15, 2023

Notification Of Non-Final Action E-Mailed

Jan 28, 2023

New Application Entered

Feb 14, 2023

New Application Office Supplied Data Entered

Oct 23, 2023

Assigned To Examiner

Nov 15, 2023

Non-Final Action Written

Nov 15, 2023

Non-Final Action E-Mailed

Feb 6, 2024

Teas Response To Office Action Received

Feb 6, 2024

Correspondence Received In Law Office

Feb 7, 2024

Teas/Email Correspondence Entered

Feb 13, 2024

Examiners Amendment -Written

Feb 13, 2024

Examiners Amendment E-Mailed

Feb 13, 2024

Notification Of Examiners Amendment E-Mailed

Feb 13, 2024

Examiner's Amendment Entered

Feb 13, 2024

Approved For Pub - Principal Register

Feb 28, 2024

Official Gazette Publication Confirmation E-Mailed

Feb 28, 2024

Notification Of Notice Of Publication E-Mailed

Mar 19, 2024

Published For Opposition

Mar 19, 2024

Official Gazette Publication Confirmation E-Mailed

May 14, 2024

Noa E-Mailed - Sou Required From Applicant